LexDanaLexDanabeta
Inventor

JOHN LIPPINCOTT

Inventor
US

Overview

6→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 6 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides32%
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
Y02ATechnologies for adaptation to climate change11%
PatentTitleYear
12,415,854Antibodies to TIGIT202511,873,339Anti-C10orf54 antibodies and uses thereof202411,820,824Antibodies to TIGIT202311,753,478Anti-CD115 antibodies202311,485,782Anti-claudin 18.2 antibodies202211,352,425Anti-CD47 antibodies2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to ABSOS LLC (1)· patent assignee history
2022Patents assigned to BEIJING XUANYI PHARMASCIENCES CO LTD (1)· patent assignee history
2022–2025Based in US· patent location history
2023–2025Patents assigned to ARCUS BIOSCIENCES INC (2)· patent assignee history
2023Patents assigned to ABLEXIS LLC (1)· patent assignee history
2024Patents assigned to PF MEDICAMENT (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ARCUS BIOSCIENCES INC22023–2025
ABLEXIS LLC12023
ABSOS LLC12022
BEIJING XUANYI PHARMASCIENCES CO LTD12022
PF MEDICAMENT12024
Locations
LocationPatentsSpan
US62022–2025